SK Biopharm posted second-quarter operating profit of 97.06 billion won ($67.9 million), up 56.9 percent from a year earlier, the company disclosed Wednesday.
Revenue for the same period rose 40.3 percent to 247.37 billion won.
Net profit for the period came to 85.06 billion won, a preliminary figure reflecting a 188.1 percent increase year on year.
jiyoon436@heraldcorp.com
